Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01787409 · ClinicalTrials.gov registry record · NA
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency
A NA study of Chronic Lymphocytic Leukemia and Diffuse Large B Cell Lymphoma, sponsored by Mayo Clinic.
- Active
- Registry status
- NA
- Development phase
- 565
- Enrollment target
- 5
- Study locations
NCT01787409 is a NA study of Chronic Lymphocytic Leukemia and Diffuse Large B Cell Lymphoma that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 565 participants, above the 179-participant average among 187 other Chronic Lymphocytic Leukemia trials with a reported enrollment target (216% higher). The trial reports 5 study locations across 5 states.
The verdict
NCT01787409, a NA study of Chronic Lymphocytic Leukemia and Diffuse Large B Cell Lymphoma, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 565 participants
- Enrollment target
- 5
- Study locations
Study Summary
This partially randomized clinical trial studies cholecalciferol in improving survival in patients with newly diagnosed cancer with vitamin D insufficiency. Vitamin D replacement may improve tumor response and survival and delay time to treatment in patients with cancer who are vitamin D insufficient.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Cholecalciferol
- OTHER Laboratory Biomarker Analysis
Study Locations (5)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Georgia
- Emory University/Winship Cancer Institute - Atlanta
Iowa
- University of Iowa/Holden Comprehensive Cancer Center - Iowa City
Minnesota
- Mayo Clinic - Rochester
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 565 participants |
| Start Date | 2013-03-06 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01787409
The ClinicalTrials.gov registry entry for NCT01787409 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 565 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 179-participant average among 187 other Chronic Lymphocytic Leukemia trials with a reported enrollment target (216% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Chronic Lymphocytic Leukemia appearing as the primary indexed condition, and to 2 interventions - of which Cholecalciferol is the first listed.
NCT01787409 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, Georgia, Iowa.
Frequently Asked Questions
What is clinical trial NCT01787409 about?
NCT01787409 is a clinical study titled "Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency". This partially randomized clinical trial studies cholecalciferol in improving survival in patients with newly diagnosed cancer with vitamin D insufficiency. Vitamin D replacement may improve tumor response and survival and delay time to treatment in patients with cancer who are vitamin D insufficien...
What is the current status of trial NCT01787409?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 565 participants. The study started on 2013-03-06. Estimated completion is 2028-06-30.
What conditions does trial NCT01787409 study?
This clinical trial studies the following conditions: Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma.
What interventions are being tested in trial NCT01787409?
The interventions under investigation include: Cholecalciferol (DIETARY_SUPPLEMENT), Laboratory Biomarker Analysis (OTHER).
Who is sponsoring clinical trial NCT01787409?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01787409 being conducted?
This trial has 5 study locations across Arizona, Georgia, Iowa, Minnesota, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Lymphocytic Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
RECRUITING · NA
-
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors
RECRUITING · NA
-
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
RECRUITING · NA
-
Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
ACTIVE NOT RECRUITING · NA
-
HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia
ACTIVE NOT RECRUITING · NA
-
Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.